The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.Meitu, a Hong Kong stock company, rose more than 10% in intraday trading, with turnover exceeding HK$ 400 million.The concept of robots has partially returned, and the Wuzhou New Year, Yuanda Intelligent daily limit, Great Wheel Intelligence, Mingke Jingji, Astar, Fengli Intelligent, Sanfeng Intelligent, etc. have followed suit.
Shanghai's state-owned assets reform index rose, with the daily limit of First Medicine, Yimin Group, Kaikai Industry and Shanghai Phoenix, and Shanghai 900 rose by more than 8%.A total of 211 cases of monkeypox have been reported in France this year. The French Public Health Agency issued a communique on the 11th, saying that 211 cases of monkeypox have been reported in France this year, including 2 new cases in the past two weeks. The communique said that these monkeypox patients are all adults, including 203 males and 8 females. According to reports, after viral gene sequencing, 168 cases were infected with monkeypox virus II, of which 61 cases were further diagnosed as infected monkeypox virus IIb. (Xinhua News Agency)Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.
Consumer stocks in Hong Kong stocks fluctuated higher, with the same journey rising by more than 6%, Mengniu Dairy rising by more than 4%, and China Resources Beer, Master Kong Holdings and Haidilao rising.Supreme Law: If the heir abandons the decedent, he shall lose the right of inheritance. On December 12th, the Supreme People's Court released the typical cases of inheritance disputes (the second batch). In case 4, Gao Moujia and Gao Xiaomou are related to each other, and Gao Xiaomou is an only child. In 1992, Gao Xiaomou (at the age of 20) left home after a dispute with his parents, and he never cared about his parents. Mother didn't take care of her when she was ill, and she didn't go to her funeral when she died. When Gao Moujia was seriously ill, he needed transportation, nursing and care for major surgery, but Gao Xiaomou did not appear. After Gao Moujia died, Gao Xiaomou ignored the burial of his ashes, but as the only legal heir, he received some bank deposit certificates under Gao Moujia's name. According to the Supreme Law, the people's court ruled that his behavior constituted abandonment according to law and sentenced him to lose the right of inheritance, which demonstrated the positive guidance of the law to social values, was conducive to carrying forward the traditional virtues of filial piety and respect for the elderly of the Chinese nation, and improved the mechanism for giving play to the role of family education and family style construction in grassroots governance.Actually, Zhijia has set up a new company to sell new energy vehicles. The enterprise search APP shows that recently, Beijing Dongwo Retail Co., Ltd. was established, with the legal representative of Li Jie and the registered capital of 10 million yuan. Its business scope includes: automobile sales; New energy vehicle sales; Wholesale of auto parts; Sales of electrical accessories for new energy vehicles; Sales of power exchange facilities for new energy vehicles. Enterprise investigation shows that the company is indirectly wholly-owned by Juran Zhijia.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide